￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Has Erdafitinib been included in the medical insurance catalog?

2026-02-01 22:25:32

Check Details
Efficacy, effects and indications of Dacomitinib/Dozerun

2026-02-01 22:25:32

Check Details
Are there generic versions of brigatinib/brigatinib?

2026-02-01 22:25:32

Check Details
What is Entrectinib/Luo Shengquan used to treat?

2026-02-01 22:25:32

Check Details
How many years do patients on acotinib/cancostat generally live?

2026-02-01 22:25:32

Check Details
The difference between pemetinib/dabotan and first, second and third generation targeted drugs

2026-02-01 22:25:32

Check Details
Is there a large number of people taking Erdafitinib/Bocco?

2026-02-01 22:25:32

Check Details
Instructions and precautions for use of Dacomitinib/Dozerun

2026-02-01 22:25:32

Check Details
Is it possible to stop taking brigatinib/brigatinib (Embry) after taking it for a long time?

2026-02-01 22:25:32

Check Details
6 major contraindications for taking entrectinib/Luo Shengquan

2026-02-01 22:25:32

Check Details
What is the main difference between acotinib/cancostat and zanubrutinib?

2026-02-01 22:25:32

Check Details
Interpretation of selumetinib/KOSELUGO: a panoramic observation from the frontier of scientific research to clinical practice

2026-02-01 22:25:32

Check Details
Category
相关知识